John J. Siekierka

The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin

F. Dumont, J. Siekierka, C. S. Lin, 1992, The Journal of experimental medicine.

Rapamycin inhibition of interleukin-2-dependent p33cdk2 and p34cdc2 kinase activation in T lymphocytes.

R. Abraham, G. Brunn, G. Wiederrecht, 1993, The Journal of biological chemistry.